Legend Biotech (LEGN) total debt

Total debt · fiscal 2025
$413.70M

Legend Biotech (LEGN) carried total debt of $413.70M at the end of fiscal 2025 (December 31, 2025). That is 18.0% higher than the $350.60M of fiscal 2024. Figures as of 18 Nov 2026, 07:18 UTC, from Yahoo Finance.

Key facts

Total debt, fiscal 2025
$413.70M
Change on fiscal 2024
+18.0%
Highest on record
$413.70Mfiscal 2025
Lowest on record
$284.53Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Legend Biotech total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $413.70M in fiscal 2025 and the lowest $284.53M in fiscal 2022.

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Legend Biotech total debt, year by year

Legend Biotech (LEGN) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$413.70M 18.0% up0.4×
2024$350.60M 6.7% up0.3×
2023$328.67M 15.5% up0.3×
2022$284.53M—0.4×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Legend Biotech and comparable companies
CompanyTotal debtFiscal year
Heartflow HTFL$22.05M2025
CRISPR Therapeutics CRSP$206.75M2025
Travere Therapeutics TVTX$328.73M2025
Option Care Health OPCH$1.27B2025
Legend Biotech LEGN$413.70M2025
Definium Therapeutics DFTX$40.58M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LEGN

Legend Biotech, figure by figure

Legend Biotech (LEGN) overview: price, valuation and scorecardAll health care companies by market value

Legend Biotech total debt: questions and answers

How much debt does Legend Biotech have?

Legend Biotech (LEGN) carried total debt of $413.70M at the end of fiscal 2025 (December 31, 2025). That is 18.0% higher than the $350.60M of fiscal 2024.

What are the highest and lowest total debt figures on record for Legend Biotech?

Across the 4 fiscal years on record (2022–2025), the highest was $413.70M in fiscal 2025 and the lowest $284.53M in fiscal 2022.

How does Legend Biotech's debt compare with its equity?

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

How is Legend Biotech's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Legend Biotech (LEGN) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/LEGN/total-debt

Underlying data: Yahoo Finance.